Tada, H <br/><br/>
Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.  [electronic resource] 

 -  The Journal of clinical investigation  Jul 2001 
 - 83-95 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI9841  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenoviridae--genetics<br/>Animals<br/>Apoptosis<br/>Colorectal Neoplasms--pathology<br/>Cytomegalovirus--genetics<br/>DNA, Complementary--administration & dosage<br/>Female<br/>Genes, Synthetic<br/>Genetic Therapy<br/>Genetic Vectors--administration & dosage<br/>Hepatocytes--metabolism<br/>Humans<br/>Injections, Intraperitoneal<br/>Injections, Intravenous<br/>Interferon-beta--administration & dosage<br/>Killer Cells, Natural--drug effects<br/>Liver Neoplasms--drug therapy<br/>Macrophages--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mice, SCID<br/>Neoplasm Transplantation<br/>Neovascularization, Pathologic--drug therapy<br/>Promoter Regions, Genetic<br/>Recombinant Fusion Proteins--administration & dosage<br/>Tumor Cells, Cultured--transplantation<br/>Xenograft Model Antitumor Assays